CMS Plans a $21B MA Payment Hike for 2026: Key Details
The Centers for Medicare & Medicaid Services (CMS) has created quite a stir by proposing a $21 billion payment increase for Medicare Advantage (MA) plans starting in 2026. If this proposal becomes reality, it will significantly shape the future of MA plans—and, by extension, the entire healthcare system. Below, we’ve broken down important details on this noteworthy proposal and what it could mean for payers, providers, and beneficiaries alike.
Overview of the Proposal
CMS plans to raise MA payments by around $21 billion in 2026—a jump notably higher than in previous years. For comparison, CMS projected a 3.32% increase in MA payments for 2024 and a 3.7% increase for 2025. This sizable infusion is designed to bolster plan benefits, help offset rising care costs, and accelerate the shift to value-based models. By allocating an estimated $9.2 trillion to MA plans over the next decade, CMS is signaling MA’s growing popularity and its pivotal role in driving innovation. However, payers argue that proposed changes to risk adjustment coding effectively amount to a payment cut.
Why Now?
Healthcare expenses have been on a steady climb, influenced by inflationary pressures, an aging population, and the long-tail effects of the COVID-19 pandemic. By proposing an increase now for 2026, CMS hopes to give insurers and providers enough lead time to prepare for changes in how these additional funds might be allocated, ensuring smoother transitions and more strategic planning.
Potential Impact on Premiums
One of the immediate questions on stakeholders’ minds is whether these increased payments will reduce out-of-pocket costs or monthly premiums for MA beneficiaries. While it is too soon to say definitively, a boosted payment rate could allow plans to lower premiums or maintain benefits at attractive rates. Alternatively, plans might use additional funds to enhance networks, offer new benefits, and fortify existing services.
Encouraging Value-Based Care
Medicare Advantage has traditionally been at the forefront of value-based care initiatives. With a larger reimbursement pool, plans could strengthen their value-based programs, invest in care coordination, and more aggressively tackle social determinants of health (SDOH). This aligns with CMS’s ongoing priority to reward high-quality, cost-effective care over volume-based approaches.
Revised Risk Adjustment Models
CMS regularly revises the Medicare Advantage risk adjustment factor (RAF score) model to more accurately reflect patient complexity. This $21 billion infusion will likely go hand-in-hand with further refinements to the model, ensuring fair compensation for plans that manage sicker or more complex patients effectively. Ultimately, precise risk adjustment can incentivize better care for high-need populations.
Star Ratings Influence
Medicare Advantage Star Ratings have become increasingly significant for both plans and beneficiaries. Higher-rated plans receive quality bonus payments and can reinvest these funds into enhanced benefits. With a larger pot of money slated for 2026, those quality bonuses could grow—making the Star Ratings process even more competitive and intensifying the focus on patient outcomes, experience, and quality improvements.
Potential Industry Challenges
While $21 billion seems like a boon, not all stakeholders are equally positioned to leverage these funds effectively. Smaller or regional MA plans may struggle to keep pace with infrastructure investments that larger insurers can more readily absorb. Additionally, there may be strings attached to CMS’s proposal, such as stricter reporting requirements or broader benefit mandates, which could create administrative hurdles.
Timeline for Approval
CMS has unveiled the broad strokes of the proposal, but the final rulemaking process can be lengthy. Stakeholders—providers, payers, and beneficiary advocacy groups—will likely have opportunities to offer comments and suggestions. Any final rule is also subject to potential legal and legislative oversight, so the exact outcome may evolve before 2026 arrives.
Implications for Healthcare Providers
An influx of funding for MA plans could also benefit healthcare providers who partner closely with these insurers. Increased reimbursements, new care coordination initiatives, and innovative pilot programs could unlock more resources for provider organizations. On the flip side, providers may face heightened expectations around quality metrics and patient experience scores.
The Bottom Line for Beneficiaries
For the millions of seniors (and some individuals with disabilities) enrolled in Medicare Advantage, this proposed payment increase could translate into richer plan benefits, expanded networks, and potentially lower premiums. However, beneficiaries should remain vigilant and revisit their plan choices annually, as details about the exact scope, availability, and cost of benefits can vary significantly from one MA plan to another.
Final Thoughts
A proposed $21 billion Medicare Advantage payment increase for 2026 has ignited robust debate across the healthcare industry. While this funding boost holds the promise of enhancing value-based care, improving beneficiary outcomes, and expanding plan offerings, its ultimate impact will hinge on CMS’s final decisions and payers’ responses. As 2026 approaches, stakeholders will closely watch ongoing rule-making developments and prepare for a new era in Medicare Advantage. The proposal remains open for public comment until February 10, 2025 with a final notice slated for publication by April 7, 2025.
For healthcare organizations looking to succeed in value-based care delivery models, ForeSee Medical is a specialized software platform designed to increase the profitability of Medicare Advantage risk contracts. Using AI including NLP in healthcare and machine learning, ForeSee Medical perfects HCC risk adjustment scores, empowering providers to positively influence health outcomes.
Blog by: The ForeSee Medical Team